Delivery Order SPE2DR25D3012-SPE2DR26F4E7P
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,926.16 to AmerisourceBergen Drug Corp for the supply of Voriconazole 200 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was awarded on December 30, 2025, with an ultimate completion date of December 31, 2025. The pharmaceutical products will be delivered to the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,771.88 firm fixed-price delivery order is for the supply of 4,567,157,701 units of Voriconazole 200 mg tablets. The contract has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Voriconazole 200 mg tablets (30-count) with a ceiling value of $14,633.76. This firm fixed-price, competitively awarded contract was finalized on July 28, 2025, with an ultimate completion date of July 29, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order does not include a set-aside designation and represents a tactical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,948.35 to AmerisourceBergen Drug Corp for the supply of Voriconazole 200 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This award represents a child contract, indicating...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,683.31 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for 4,564,274,187 units of the pharmaceutical product VORICONAZOLE 200 MG TABLET 30S. This delivery order was issued against an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
- This federal contract award is for the delivery of voriconazole 200 mg vials to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $1,540.80 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VORICONAZOLE 200 MG TABLET 30S. The contract has a firm fixed price of $6,045.67 and a completion date of November 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which...
- The Defense Logistics Agency awarded a delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on January 7, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $27,094.95. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,094.95 and an ultimate completion date of August 8, 2025. This is a non-set-aside, competitively awarded delivery order utilizing an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4E7PDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,502.43 to AmerisourceBergen Drug Corp for the supply of Voriconazole 40 mg/ml suspension in 75ml quantities. This award, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, represents a firm fixed-price, non-set-aside competitive procurement. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement needs. The company serves multiple federal healthcare systems including the Defense Health Agency and U.S. Coast Guard through its extensive portfolio of pharmaceutical deliveries. Cencora, Inc. holds the primary IDC with DLA valued at up to $999,999,999.00 through December 2031, demonstrating the company's significant role in supplying essential medications and medical commodities to military treatment facilities and other federal medical institutions. Voriconazole is an antifungal medication commonly used in military and veteran healthcare settings for treating serious fungal infections.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 1/8/26 |